AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 Growth ETF
IWF
|
+$630M |
| 2 |
Visa
V
|
+$363M |
| 3 |
MSCI
MSCI
|
+$322M |
| 4 |
Walt Disney
DIS
|
+$297M |
| 5 |
Monster Beverage
MNST
|
+$281M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$584M |
| 2 |
Nike
NKE
|
+$573M |
| 3 |
Meta Platforms (Facebook)
META
|
+$489M |
| 4 |
Adobe
ADBE
|
+$418M |
| 5 |
Advanced Micro Devices
AMD
|
+$416M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.76% |
| 2 | Healthcare | 17.68% |
| 3 | Financials | 13.09% |
| 4 | Consumer Discretionary | 10.62% |
| 5 | Industrials | 9.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2776
Modine Manufacturing
MOD
$10.7B
| $369K | ﹤0.01% |
28,500
| – | – |
|
2777
UFP Technologies
UFPT
$1.97B
| $369K | ﹤0.01% |
4,300
+800
| +23% | +$70.1K |
|
|
GOEV
2778
DELISTED
Canoo Inc. Class A Common Stock
GOEV
| $369K | ﹤0.01% |
428
+218
| +104% | +$318K |
|
|
INST
2779
DELISTED
Instructure Holdings, Inc.
INST
| $368K | ﹤0.01% |
16,500
+7,000
| +74% | +$163K |
|
2780
Cass Information Systems
CASS
$714M
| $367K | ﹤0.01% |
10,566
| – | – |
|
2781
LendingTree
TREE
$447M
| $367K | ﹤0.01% |
15,375
-262
| -2% | -$10.2K |
|
2782
CAE Inc. Common Shares
CAE
$8.3B
| $365K | ﹤0.01% |
23,811
-259
| -1% | -$5.54K |
|
2783
Nuvation Bio
NUVB
$2.2B
| $365K | ﹤0.01% |
162,994
| – | – |
|
2784
Pennant Group
PNTG
$1.4B
| $363K | ﹤0.01% |
34,887
+176
| +0.5% | +$2.52K |
|
2785
Arlo Technologies
ARLO
$1.6B
| $362K | ﹤0.01% |
78,114
+6,794
| +10% | +$42.6K |
|
2786
Stoneridge
SRI
$195M
| $361K | ﹤0.01% |
21,300
| – | – |
|
|
BFS
2787
Saul Centers
BFS
$836M
| $360K | ﹤0.01% |
9,588
+637
| +7% | +$29.4K |
|
2788
BlueLinx
BXC
$422M
| $360K | ﹤0.01% |
5,800
| – | – |
|
2789
ROBO Global Robotics & Automation Index ETF
ROBO
$1.96B
| $360K | ﹤0.01% |
8,711
+3,050
| +54% | +$144K |
|
2790
Ocular Therapeutix
OCUL
$1.79B
| $359K | ﹤0.01% |
86,400
-5,300
| -6% | -$26.7K |
|
|
SPGS
2791
DELISTED
Simon Property Group Acquisition Holdings, Inc.
SPGS
| $355K | ﹤0.01% |
36,000
| – | – |
|
2792
Design Therapeutics
DSGN
$761M
| $354K | ﹤0.01% |
21,200
+7,200
| +51% | +$143K |
|
2793
Greif Class B
GEF.B
$4.11B
| $353K | ﹤0.01% |
5,800
+1,200
| +26% | +$79.1K |
|
2794
Hackett Group
HCKT
$270M
| $353K | ﹤0.01% |
19,897
+1,300
| +7% | +$26.4K |
|
2795
Stoke Therapeutics
STOK
$1.8B
| $353K | ﹤0.01% |
27,500
+3,800
| +16% | +$60.6K |
|
2796
Arrow Financial
AROW
$659M
| $351K | ﹤0.01% |
12,528
+760
| +6% | +$23.5K |
|
2797
Movado Group
MOV
$849M
| $351K | ﹤0.01% |
12,452
-990
| -7% | -$32.4K |
|
|
PNT
2798
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $348K | ﹤0.01% |
45,000
+31,800
| +241% | +$270K |
|
2799
Rigel Pharmaceuticals
RIGL
$681M
| $347K | ﹤0.01% |
29,444
| – | – |
|
2800
Gorman-Rupp
GRC
$2.14B
| $346K | ﹤0.01% |
14,537
-5,425
| -27% | -$147K |
|
Similar funds
AllianceBernstein's Q3 2022 Portfolio in Review
As of Q3 2022, AllianceBernstein held 3,359 positions worth $207B, down 5.7% from $219B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
AllianceBernstein's Q3 2022 filing shows 102 new, 1,361 increased, 1,417 reduced and 89 closed positions. Its largest new stake was Genmab: 5,779,489 shares worth $186M. The largest sale was Qualcomm, an estimated $584M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.
- AllianceBernstein's largest Q3 2022 buy was Genmab: 5,779,489 shares worth $186M.
- AllianceBernstein added most to iShares Russell 1000 Growth ETF in Q3 2022, an estimated $630M increase.
- AllianceBernstein's biggest Q3 2022 reduction was Qualcomm, cutting an estimated $584M.
- AllianceBernstein fully exited American Campus Communities, Inc. in Q3 2022, selling an estimated $244M.
- AllianceBernstein's ten largest holdings make up 23% of its $207B portfolio in Q3 2022.
- AllianceBernstein opened 102 new positions and closed 89 in Q3 2022.
- AllianceBernstein's portfolio value fell 5.7% quarter-over-quarter to $207B.
Based on AllianceBernstein's 13F filing for Q3 2022, filed 15 Nov 2022.